Cobra Venom Painkiller Co. Inks Deal To Settle SEC Claims - Law360

NPHC Stock  USD 0.0001  0.00  0.00%   
About 55% of Nutra Pharma's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Nutra Pharma Corp pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Nutra Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Nutra Pharma Corp stock news signals to limit their universe of possible portfolio assets.
  
Cobra Venom Painkiller Co. Inks Deal To Settle SEC Claims Law360

Read at news.google.com
Google News at Macroaxis
  

Nutra Pharma Fundamental Analysis

We analyze Nutra Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutra Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutra Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

100%
Nutra Pharma is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Peers

Trending Equities

AA  1.49   
0%
46.0%
UPS  1.03   
0%
32.0%
CVX  0.74   
0%
23.0%
AAPL  0.18   
0%
5.0%
BBY  0.13   
0%
4.0%
T  0.08   
2.0%
0%
IBM  0.51   
15.0%
0%
MET  0.63   
19.0%
0%
HD  0.95   
29.0%
0%
CVS  1.40   
43.0%
0%
AAL  1.44   
45.0%
0%
TGT  1.44   
45.0%
0%
WFC  2.30   
72.0%
0%
S  2.73   
85.0%
0%
C  2.94   
92.0%
0%
INTC  3.19   
100.0%
0%

Complementary Tools for Nutra Pink Sheet analysis

When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Share Portfolio
Track or share privately all of your investments from the convenience of any device
News Freq…Investor S…